IRWD - Ironwood Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.04 revenue of $113.74M beats by $0.92M
2023-11-09 07:03:18 ET
More on Ironwood Pharmaceuticals
- Ironwood Pharmaceuticals: The Right Play Now
- Ironwood: Pipeline Progresses As FDA Approves LINZESS
- Ironwood Pharmaceuticals Q3 2023 Earnings Preview
- JMP starts Ironwood at market outperform, cites potential of GLP-2 drug
- Seeking Alpha’s Quant Rating on Ironwood Pharmaceuticals
For further details see:
Ironwood Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.04, revenue of $113.74M beats by $0.92M